Table 4 The validation result of top 20 new DDIs of drug Ranolazine (DB00243) predicted by DDIGIP method in de novo validation
From: DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels
Rank | Drug ID1 | Drug ID2 | Evidence |
|---|---|---|---|
1 | DB00243 | DB00451 | TWOSIDES,DrugBanK |
2 | Â | DB00338 | TWOSIDES,DrugBanK |
3 | Â | DB00641 | TWOSIDES,DrugBanK |
4 | Â | DB00945 | TWOSIDES,DrugBanK |
5 | Â | DB00758 | TWOSIDES,DrugBanK |
6 | Â | DB00316 | DrugBanK |
7 | Â | DB00264 | TWOSIDES |
8 | Â | DB00695 | TWOSIDES |
9 | Â | DB00722 | TWOSIDES |
10 | Â | DB00390 | TWOSIDES,DrugBanK |
11 | Â | DB00448 | TWOSIDES,DrugBanK |
12 | Â | DB00999 | TWOSIDES |
13 | Â | DB00863 | TWOSIDES,DrugBanK |
14 | Â | DB00630 | TWOSIDES |
15 | Â | DB00635 | DrugBanK |
16 | Â | DB00213 | TWOSIDES,DrugBanK |
17 | Â | DB00678 | TWOSIDES,DrugBanK |
18 | Â | DB00425 | TWOSIDES,DrugBanK |
19 | Â | DB00177 | TWOSIDES |
20 | Â | DB00331 | TWOSIDES,DrugBanK |